77.16
Precedente Chiudi:
$78.96
Aprire:
$79.03
Volume 24 ore:
1.01M
Relative Volume:
0.88
Capitalizzazione di mercato:
$3.27B
Reddito:
-
Utile/perdita netta:
$-63.78M
Rapporto P/E:
-28.79
EPS:
-2.68
Flusso di cassa netto:
$-53.91M
1 W Prestazione:
+8.72%
1M Prestazione:
+56.19%
6M Prestazione:
+592.64%
1 anno Prestazione:
+397.81%
Celcuity Inc Stock (CELC) Company Profile
Nome
Celcuity Inc
Settore
Industria
Telefono
763-392-0767
Indirizzo
16305 36TH AVENUE N, MINNEAPOLIS, MN
Confronta CELC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CELC
Celcuity Inc
|
77.16 | 3.35B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-22 | Iniziato | Guggenheim | Buy |
| 2025-07-01 | Ripresa | Stifel | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-02-22 | Iniziato | Stifel | Buy |
| 2023-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-07 | Iniziato | Jefferies | Buy |
| 2021-07-29 | Iniziato | Cowen | Outperform |
| 2021-07-27 | Iniziato | Needham | Buy |
| 2021-01-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-11 | Ripresa | Craig Hallum | Buy |
| 2018-11-20 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Celcuity Inc Borsa (CELC) Ultime notizie
Sector ETF performance correlation with Celcuity Inc.Gap Up & Safe Capital Allocation Plans - newser.com
Will Celcuity Inc. stock benefit from AI adoptionQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Price action breakdown for Celcuity Inc.Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Why analysts upgrade Celcuity Inc. stockQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
How to track smart money flows in Celcuity Inc.Analyst Downgrade & Daily Price Action Insights - newser.com
What institutional flow reveals about Celcuity Inc.Market Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Candlestick signals on Celcuity Inc. stock todayJuly 2025 Institutional & Expert Approved Trade Ideas - newser.com
How buybacks impact Celcuity Inc. stock valueTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Celcuity (CELC) Is Up 11.9% After Revealing Efficacy of Gedatolisib in ESMO Trial Results - simplywall.st
Celcuity : Corporate Presentation (Celcuity Investor Presentation V.7.1.2 Final) - MarketScreener
Celcuity (CELC) Price Target Increased by 10.74% to 84.15 - Nasdaq
When is the best time to exit Celcuity Inc.Oil Prices & Reliable Entry Point Trade Alerts - newser.com
How currency fluctuations impact Celcuity Inc. stockEarnings Beat & Technical Buy Zone Confirmation - newser.com
What analysts say about Celcuity Inc stockVolatility Trading Techniques & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Published on: 2025-10-27 20:00:39 - newser.com
Is It Too Late to Buy Celcuity Stock? - StocksToTrade
Celcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer? - TipRanks
Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer? - TipRanks
Celcuity Shares Surge Amid Promising Cancer Study - TipRanks
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors - TipRanks
Celcuity Inc Azioni (CELC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):